Early research (Phase 1)Study completedNCT05903794What this trial is testingEXG102-031 in Patients With wAMD (Everest)Who this might be right forNeovascular (Wet) Age-related Macular Degeneration (nAMD) Exegenesis Bio 12
Post-approval studies (Phase 4)Study completedNCT05269966What this trial is testingStudy to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)Who this might be right forNeovascular Age-related Macular Degeneration (nAMD) Novartis Pharmaceuticals 105
Testing effectiveness (Phase 2)Study completedNCT03479372What this trial is testingStudy of PAN-90806 Eye Drops, Suspension for Neovascular AMDWho this might be right forNeovascular Age-related Macular Degeneration PanOptica, Inc. 51
Testing effectiveness (Phase 2)Ended earlyNCT00464347What this trial is testingTAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular DegenerationWho this might be right forAge-Related Macular Degeneration National Eye Institute (NEI) 100
Early research (Phase 1)Study completedNCT07484074What this trial is testingA Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324Who this might be right forDiabetic Macular Edema (DME)Neovascular (Wet) Age-Related Macular Degeneration Ollin Biosciences, Inc. 164
Testing effectiveness (Phase 2)Study completedNCT01494805What this trial is testingSafety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular DegenerationWho this might be right forMacular DegenerationAge-related MaculopathiesAge-related Maculopathy+5 more Lions Eye Institute, Perth, Western Australia 40
Large-scale testing (Phase 3)Active Not RecruitingNCT06556368What this trial is testingEvaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAKWho this might be right forWet Age-related Macular Degeneration Kodiak Sciences Inc 675
Post-approval studies (Phase 4)Study completedNCT01453920What this trial is testingWet AMD Recurrence Rate in Patients Stable on Three Month Ranibizumab DosingWho this might be right forAge Related Macular Degeneration University Health Network, Toronto 44
Large-scale testing (Phase 3)Active Not RecruitingNCT06856577What this trial is testingEfficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular DegenerationWho this might be right forNeovascular Age-Related Macular Degeneration (nAMD)Wet AMD Adverum Biotechnologies, Inc. 311
Testing effectiveness (Phase 2)UnknownNCT00996684What this trial is testingStudy of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular DegenerationWho this might be right forMacular Degeneration University of California, Los Angeles 30
Post-approval studies (Phase 4)Looking for participantsNCT05093374What this trial is testingTreatment of Neovascular AMD: Artificial Intelligence in Real-world SettingWho this might be right forExudative Macular Degeneration Medical University of Vienna 290
Testing effectiveness (Phase 2)Looking for participantsNCT07587515What this trial is testingPhase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular DegenerationWho this might be right forNeovascular (Wet) Age-Related Macular Degeneration Eyconis INC. 30
Large-scale testing (Phase 3)Study completedNCT02157077What this trial is testingAflibercept After Ranibizumab in Exudative Age-related Macular DegenerationWho this might be right forMacular DegenerationWet Macular DegenerationRetinal Degeneration+2 more Centre Hospitalier Intercommunal Creteil 90
Post-approval studies (Phase 4)UnknownNCT01670162What this trial is testingOn-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Detachments in Neovascular Age Related Macular Degeneration (AMD)Who this might be right forAge Related Macular DegenerationPigment Epithelial Detachment Tennessee Retina 30
Testing effectiveness (Phase 2)Study completedNCT00607750What this trial is testingSafety and Efficacy of ATG003 in Patients With AMD Receiving Anti-VEGFWho this might be right forAge-Related Macular Degeneration CoMentis 60
Testing effectiveness (Phase 2)Study completedNCT05637255What this trial is testingA Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD)Who this might be right forWet Macular DegenerationNeovascular Age-related Macular DegenerationMacular Degeneration Sylentis, S.A. 99
Not applicableEnded earlyNCT02005133What this trial is testingA Prospective, Observational, Multicentre, 2 Year Study Evaluating the Use of Eylea (Aflibercept) for the Treatment of Neovascular (Wet) Age-related Macular Degeneration in UK NHS Opthalmology ClinicsWho this might be right forWet Age-related Macular Degeneration Novartis Pharmaceuticals 188
Testing effectiveness (Phase 2)Active Not RecruitingNCT05230537What this trial is testingA Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular DegenerationWho this might be right forAge-Related Macular Degeneration Novartis Pharmaceuticals 168
Early research (Phase 1)Not Yet RecruitingNCT07764965What this trial is testingEvaluation of PAN-90806 Eye Drops in Healthy SubjectsWho this might be right forWet Age Related Macular DegenerationNeovascular (Wet) Age-Related Macular Degeneration Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. 20
Large-scale testing (Phase 3)Study completedNCT04264819What this trial is testingStudy of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular DegenerationWho this might be right forNeovascular Age-Related Macular Degeneration Novartis Pharmaceuticals 295